2Kim KK, Lee JJ, Yang Y, et al. Macrophage inhibitory cytokin-1 activates AKT and ERK-1/2 via the transactivation of ErbB2 in human breast and gastric cancer cells[J].Carcinogenesis,2008,29(4): 704-712.
3Jiang BH, Liu LZ. PI3K/PTEN signaling in tumorigenesis and angiogenesis[J].Biochim Biophys Acta,2008,1784(1):150-158.
4Yang MH, Wu MZ, Chiou SH, et al. Direct regulation of TWIST by HIF-lalpha promotes metastasis[J]. Nat Cell Biol,2008,10(3): 295-305.
5Maynard MA, Ohh M. The role of hypoxia-inducible factors in cancer [J]. Cell Mol Life Sci,2007,64(16):2170-2180.
6Garlich JR, De P, Dey N, et al. A vascular targeted pan phosphoinositide 3-kinase inhibitor prodrug, SFl126,with antitumor and antiangiogenic activity[J]. Cancer Res,2008,68(1):206-215.
7Jin Ho, An S, Lee HC, et al. Hypoxic condition-and high cell density-induced expression of Reddl is regulated by activation of hypoxia-inducible factor-1 alpha and spl through the phosphati- dylinositol 3-kinase/AKT signaling pathway[J]. Cell Signal, 2007,19 (7):1393-1403.
8Zhang D, Fan D. Mutidrug resistance in gastfie cancer: recent research advances and ongoing therapeutic challenges[J].Exp Rev Anticancer Ther, 2007,7( 10): 1369-1378.
9Lang SA, Gaumann A, Koehl GE, et al. Mammalian target of rapamycin is activated in human gastric cancer and serves as a target for therapy in an experimental model[J]. Int J Cancer, 2007, 120(8): 1803-1810.
10Marone R, Cmiljanovic V, Giese B, et al. Targeting phosphoinositide 3-kinase-moving towards therapy[J].Biochim Biophys Acta,2008, 1784(1):159-185.
1Hao J, Song X, Song B, et al.. Effects of lentivims-mediated HIF-1 alpha knockdown on hypoxia-elated cisplatin resistance and their dependence on p53 status in fibrosarcoma cells[J]. Cancer Gene Ther ,2008,15(7): 449.
2Ke Q, Costa M. Hypoxia-inducible factor-1 (HIF-1)[J]. Mol Pharmacol, 2006,70 (5) : 1469-1480.
3Esteban MA, Tran MG, Harten SK, et al.. Regulation of E-eadherin expression by VHL and hypoxia-inducible factor[J]. Cancer Res ,2006,66(7) :3567-3575.
4Kashiwagi S, Yashiro M, Takashima T, et al.. Significance of E-cadherin expression in triple-negative breast cancer[J]. Br J Cancer, 2010,103(2): 249-255.
